share_log

D. Boral Capital Initiates Coverage On CervoMed With Buy Rating, Announces Price Target of $34

D. Boral Capital Initiates Coverage On CervoMed With Buy Rating, Announces Price Target of $34

D. Boral Capital對CervoMed進行覆蓋,給予買入評級,宣佈目標價爲34美元。
Benzinga ·  11/18 10:16  · 評級/大行評級

D. Boral Capital analyst Jason Kolbert initiates coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and announces Price Target of $34.

D. Boral Capital分析師傑森·科爾伯特以買入評級啓動了對CervoMed(納斯達克股票代碼:CRVO)的報道,並宣佈目標股價爲34美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論